Adipose derived allogenic mesenchymal stem cells Therapy(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)

脂肪来源的异体间充质干细胞治疗（Instituto De Investigación Sanitaria De La Fundación Jiménez Díaz(Instituto De Investigación Sanitaria De La Fundación Jiménez Díaz）

Report date: 2025/02/02 20:00:08

Base Information

Drug NameAdipose derived allogenic mesenchymal stem cells Therapy(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)

Drug Alias NameAdipose derived allogenic mesenchymal stem cells (adAMSC)Adipose derived allogenic mesenchymal stem cellsadAMSC

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstituto De Investigación Sanitaria De La Fundación Jiménez Díaz

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstituto De Investigación Sanitaria De La Fundación Jiménez Díaz

Active IndicationsN/A

Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A